Stock Events

Stock Events

Agile Therapeutics

0

54

+€0.00+0% 00:00 Today

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Evofem Biosciences

Evofem Biosciences develops and markets women's sexual and reproductive health products, directly competing with Agile's contraceptive solutions.

Pfizer offers a wide range of contraceptive products, making it a direct competitor in the women's healthcare market.

Teva- Pharmaceutical Industries

Teva Pharmaceutical Industries has a significant presence in the generic and specialty women's health products, including contraceptives.

Merck & Co. offers contraceptive products and vaccines that target the same market as Agile Therapeutics.

Perrigo Company

Perrigo Company plc offers a range of over-the-counter women's health products, competing in the broader women's healthcare market.

Novo Nordisk has a focus on women's health, particularly in hormone replacement therapies, which can be seen as an alternative to contraceptives.

Johnson & Johnson

Johnson & Johnson, through its subsidiaries, provides a variety of women's health products, including contraceptives, making it a competitor.

About

AGILE THERAPEUTICS WTS

Show More

CEO

Country

Germany

ISIN

US00847L1008

WKN

000A3DKKE

Listings

0 Comments

Share your thoughts

FAQs

What is Agile Therapeutics stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Agile Therapeutics stocks are traded under the ticker 0AL.STU.

In which sector is Agile Therapeutics located?▼

Agile Therapeutics operates in the Other sector.

When did Agile Therapeutics complete a stock split?▼

The last stock split for Agile Therapeutics was on April 27, 2022 with a ratio of 1:40.